ASLAN Pharmaceuticals Statistics

Total Valuation

ASLN has a market cap or net worth of $9.90 million. The enterprise value is $13.67 million.

Market Cap	9.90M
Enterprise Value	13.67M

Important Dates

The last earnings date was Friday, April 12, 2024, before market open.

Earnings Date	Apr 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ASLN has 17.60 million shares outstanding.

Shares Outstanding	17.60M
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	15.49%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.67
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.84

Current Ratio	1.84
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.18

Financial Efficiency

Return on equity (ROE) is -8,453.60% and return on invested capital (ROIC) is -320.96%.

Return on Equity (ROE)	-8,453.60%
Return on Assets (ROA)	-95.70%
Return on Capital (ROIC)	-320.96%
Revenue Per Employee	$342,857
Profits Per Employee	-$1.26M
Employee Count	35
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

In the past 12 months, ASLN has paid $132,667 in taxes.

Income Tax	132,667
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.17% in the last 52 weeks. The beta is 1.47, so ASLN's price volatility has been higher than the market average.

Beta (1Y)	1.47
52-Week Price Change	-89.17%
50-Day Moving Average	0.61
200-Day Moving Average	1.20
Relative Strength Index (RSI)	41.28
Average Volume (30 Days)	1,183,783

Short Selling Information

Short Interest	116,785
Short Previous Month	290,509
Short % of Shares Out	0.52%
Short % of Float	n/a
Short Ratio (days to cover)	0.05

Income Statement

In the last 12 months, ASLN had revenue of $12.00 million and -$44.22 million in losses. Loss per share was -$2.75.

Revenue	12.00M
Gross Profit	12.00M
Operating Income	-43.74M
Pretax Income	-44.09M
Net Income	-44.22M
EBITDA	-39.41M
EBIT	-39.76M
Loss Per Share	-$2.75

Full Income Statement

Balance Sheet

The company has $21.25 million in cash and $26.91 million in debt, giving a net cash position of -$5.66 million or -$0.32 per share.

Cash & Cash Equivalents	21.25M
Total Debt	26.91M
Net Cash	-5.66M
Net Cash Per Share	-$0.32
Equity / Book Value	-13.29M
Book Value Per Share	-0.76
Working Capital	11.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.32 million and capital expenditures -$10,633, giving a free cash flow of -$43.33 million.

Operating Cash Flow	-43.32M
Capital Expenditures	-10,633
Free Cash Flow	-43.33M
FCF Per Share	-$2.52

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -364.46% and -368.50%.

Gross Margin	100.00%
Operating Margin	-364.46%
Pretax Margin	-367.39%
Profit Margin	-368.50%
EBITDA Margin	-328.39%
EBIT Margin	-331.29%
FCF Margin	-361.09%

Dividends & Yields

ASLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.32%
Shareholder Yield	-23.32%
Earnings Yield	-552.29%
FCF Yield	-541.18%

Analyst Forecast

The average price target for ASLN is $11.33, which is 2,236.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.33
Price Target Difference	2,236.08%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 13, 2023. It was a reverse split with a ratio of 1:5.

Last Split Date	Mar 13, 2023
Split Type	Reverse
Split Ratio	1:5

Scores

ASLN has an Altman Z-Score of -22.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.43
Piotroski F-Score	2